Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 1
2005 6
2006 3
2007 5
2008 11
2009 7
2010 17
2011 13
2012 20
2013 13
2014 9
2015 10
2016 20
2017 8
2018 14
2019 9
2020 8
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Results by year
Filters applied: . Clear all
Page 1
Migrating into the Tumor: a Roadmap for T Cells.
van der Woude LL, Gorris MAJ, Halilovic A, Figdor CG, de Vries IJM. van der Woude LL, et al. Among authors: de vries ijm. Trends Cancer. 2017 Nov;3(11):797-808. doi: 10.1016/j.trecan.2017.09.006. Epub 2017 Nov 6. Trends Cancer. 2017. PMID: 29120755 Review.
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
Bol KF, Schreibelt G, Gerritsen WR, de Vries IJ, Figdor CG. Bol KF, et al. Among authors: de vries ij. Clin Cancer Res. 2016 Apr 15;22(8):1897-906. doi: 10.1158/1078-0432.CCR-15-1399. Clin Cancer Res. 2016. PMID: 27084743 Free article. Review.
Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage.
Heger L, Hofer TP, Bigley V, de Vries IJM, Dalod M, Dudziak D, Ziegler-Heitbrock L. Heger L, et al. Among authors: de vries ijm. Front Immunol. 2020 Sep 30;11:559166. doi: 10.3389/fimmu.2020.559166. eCollection 2020. Front Immunol. 2020. PMID: 33101275 Free PMC article. Review.
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.
Daillère R, Derosa L, Bonvalet M, Segata N, Routy B, Gariboldi M, Budinská E, De Vries IJM, Naccarati AG, Zitvogel V, Caldas C, Engstrand L, Loilbl S, Fieschi J, Heinzerling L, Kroemer G, Zitvogel L. Daillère R, et al. Among authors: de vries ijm. Oncoimmunology. 2020 Jun 3;9(1):1774298. doi: 10.1080/2162402X.2020.1774298. Oncoimmunology. 2020. PMID: 32934879 Free PMC article. Review.
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.
Westdorp H, Creemers JHA, van Oort IM, Schreibelt G, Gorris MAJ, Mehra N, Simons M, de Goede AL, van Rossum MM, Croockewit AJ, Figdor CG, Witjes JA, Aarntzen EHJG, Mus RDM, Brüning M, Petry K, Gotthardt M, Barentsz JO, de Vries IJM, Gerritsen WR. Westdorp H, et al. Among authors: de vries ijm. J Immunother Cancer. 2019 Nov 14;7(1):302. doi: 10.1186/s40425-019-0787-6. J Immunother Cancer. 2019. PMID: 31727154 Free PMC article. Clinical Trial.
165 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page